LT3083554T - Dimetilbenzoinės rūgšties junginiai - Google Patents
Dimetilbenzoinės rūgšties junginiaiInfo
- Publication number
- LT3083554T LT3083554T LTEP14827908.6T LT14827908T LT3083554T LT 3083554 T LT3083554 T LT 3083554T LT 14827908 T LT14827908 T LT 14827908T LT 3083554 T LT3083554 T LT 3083554T
- Authority
- LT
- Lithuania
- Prior art keywords
- acid compounds
- dimethylbenzoic acid
- dimethylbenzoic
- compounds
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
- C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361916824P | 2013-12-17 | 2013-12-17 | |
| PCT/US2014/069783 WO2015094912A1 (en) | 2013-12-17 | 2014-12-11 | Dimethylbenzoic acid compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3083554T true LT3083554T (lt) | 2019-05-10 |
Family
ID=52355186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP14827908.6T LT3083554T (lt) | 2013-12-17 | 2014-12-11 | Dimetilbenzoinės rūgšties junginiai |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10005721B2 (lt) |
| EP (1) | EP3083554B1 (lt) |
| JP (1) | JP6200596B2 (lt) |
| KR (1) | KR101937186B1 (lt) |
| CN (1) | CN105793236B (lt) |
| AU (1) | AU2014366371B2 (lt) |
| CA (1) | CA2929562A1 (lt) |
| CY (1) | CY1121677T1 (lt) |
| DK (1) | DK3083554T3 (lt) |
| EA (1) | EA028675B1 (lt) |
| ES (1) | ES2727329T3 (lt) |
| HR (1) | HRP20190793T1 (lt) |
| HU (1) | HUE043614T2 (lt) |
| LT (1) | LT3083554T (lt) |
| ME (1) | ME03398B (lt) |
| MX (1) | MX368178B (lt) |
| PL (1) | PL3083554T3 (lt) |
| PT (1) | PT3083554T (lt) |
| RS (1) | RS58594B1 (lt) |
| SA (1) | SA516371324B1 (lt) |
| SI (1) | SI3083554T1 (lt) |
| TR (1) | TR201904327T4 (lt) |
| WO (1) | WO2015094912A1 (lt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10189788B2 (en) * | 2014-09-09 | 2019-01-29 | Bayer Pharma Aktiengesellschaft | Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents |
| US10745382B2 (en) * | 2015-10-15 | 2020-08-18 | Bristol-Myers Squibb Company | Compounds useful as immunomodulators |
| CR20180323A (es) | 2015-11-20 | 2018-08-06 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituídos como moduladores de los receptores de pge2 |
| WO2017153235A1 (de) * | 2016-03-09 | 2017-09-14 | Bayer Pharma Aktiengesellschaft | Substituierte n-cyclo-3-aryl-1-naphthamide und ihre verwendung |
| TWI770157B (zh) | 2017-04-10 | 2022-07-11 | 德商拜耳廠股份有限公司 | 經取代之n-芳基乙基-2-胺基喹啉-4-甲醯胺及其用途 |
| CN110730776A (zh) | 2017-04-10 | 2020-01-24 | 拜耳股份公司 | 取代的n-芳基乙基-2-芳基喹啉-4-甲酰胺及其用途 |
| KR102650756B1 (ko) | 2017-05-18 | 2024-03-22 | 이도르시아 파마슈티컬스 리미티드 | N-치환된 인돌 유도체 |
| US11446298B2 (en) | 2017-05-18 | 2022-09-20 | Idorsia Pharmaceuticals Ltd | Pyrimidine derivatives |
| RS62398B1 (sr) | 2017-05-18 | 2021-10-29 | Idorsia Pharmaceuticals Ltd | Derivati pirimidina kao modulatori receptora pge2 |
| CN110621671A (zh) | 2017-05-18 | 2019-12-27 | 爱杜西亚药品有限公司 | 作为pge2受体调节剂的苯并呋喃及苯并噻吩衍生物 |
| US11712438B2 (en) | 2017-05-18 | 2023-08-01 | Idorsia Pharmaceuticals Ltd | Phenyl derivatives as PGE2 receptor modulators |
| WO2020151566A1 (zh) * | 2019-01-22 | 2020-07-30 | 凯复制药有限公司 | 抑制pge2/ep4信号传导的化合物、其制备方法及其在医药上的应用 |
| EP4245301A1 (en) | 2020-11-13 | 2023-09-20 | ONO Pharmaceutical Co., Ltd. | Cancer treatment by combined use of ep4 antagonist and immune checkpoint inhibitor |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1270615B (it) * | 1994-07-14 | 1997-05-07 | Smithkline Beecham Farma | Uso di derivati di chinolina |
| TW502026B (en) * | 1995-06-20 | 2002-09-11 | Zeneca Ltd | Aromatic compounds useful as antagonists of e-type prostaglandins, processes for the preparation thereof, pharmaceutical compositions comprising the compounds, and intermediates |
| ES2246830T3 (es) * | 1999-03-17 | 2006-03-01 | Astrazeneca Ab | Derivados de amida. |
| AP2006003534A0 (en) * | 2003-09-03 | 2006-04-30 | Pfizer | Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists. |
| MXPA06003123A (es) | 2003-09-22 | 2006-05-31 | Euro Celtique Sa | Agentes terapeuticos utiles para el tratamiento del dolor. |
| GB0324269D0 (en) * | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| US7326732B2 (en) | 2004-02-12 | 2008-02-05 | Pharmagene Laboratories Limited | EP2 receptor agonists |
| CN1950334A (zh) * | 2004-05-04 | 2007-04-18 | 辉瑞有限公司 | 邻位取代的芳基或杂芳基酰胺化合物 |
| US20070054916A1 (en) * | 2004-10-01 | 2007-03-08 | Amgen Inc. | Aryl nitrogen-containing bicyclic compounds and methods of use |
| AU2007260529B2 (en) | 2006-06-12 | 2012-04-19 | Merck Canada Inc. | Indoline amide derivatives as EP4 receptor ligands |
| CA2692265A1 (en) * | 2007-07-03 | 2009-01-08 | Astellas Pharma Inc. | Amide compounds |
| WO2010043592A1 (en) | 2008-10-15 | 2010-04-22 | Revotar Biopharmaceuticals Ag | Lipase inhibitors for use for the treatment of obesity |
| JP5602641B2 (ja) * | 2009-01-30 | 2014-10-08 | 富山化学工業株式会社 | Ｎ−アシルアントラニル酸誘導体またはその塩 |
| EP2415755A4 (en) * | 2009-03-31 | 2012-09-19 | Renascience Co Ltd | INHIBITOR AGENT OF PLASMINOGEN ACTIVATOR INHIBITOR 1 |
| WO2012004293A2 (de) | 2010-07-08 | 2012-01-12 | Bayer Cropscience Ag | Insektizide und fungizide wirkstoffkombinationen |
| US20140057953A1 (en) | 2011-03-03 | 2014-02-27 | Rolf Hartmann | Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors |
| EP2751080B1 (en) * | 2011-08-31 | 2015-10-28 | Amakem NV | Novel soft rock inhibitors |
| EP2755944B1 (en) * | 2011-09-16 | 2017-06-14 | Sanofi | Biarylderivatives,their preparation and their therapeutic application |
| TWI572597B (zh) * | 2012-06-29 | 2017-03-01 | 美國禮來大藥廠 | 二甲基－苯甲酸化合物 |
| EP2765128A1 (en) * | 2013-02-07 | 2014-08-13 | Almirall, S.A. | Substituted benzamides with activity towards EP4 receptors |
-
2014
- 2014-12-11 MX MX2016007861A patent/MX368178B/es active IP Right Grant
- 2014-12-11 AU AU2014366371A patent/AU2014366371B2/en not_active Ceased
- 2014-12-11 CN CN201480066576.6A patent/CN105793236B/zh not_active Expired - Fee Related
- 2014-12-11 PT PT14827908T patent/PT3083554T/pt unknown
- 2014-12-11 WO PCT/US2014/069783 patent/WO2015094912A1/en active Application Filing
- 2014-12-11 TR TR2019/04327T patent/TR201904327T4/tr unknown
- 2014-12-11 ES ES14827908T patent/ES2727329T3/es active Active
- 2014-12-11 HU HUE14827908A patent/HUE043614T2/hu unknown
- 2014-12-11 ME MEP-2019-106A patent/ME03398B/me unknown
- 2014-12-11 EP EP14827908.6A patent/EP3083554B1/en active Active
- 2014-12-11 LT LTEP14827908.6T patent/LT3083554T/lt unknown
- 2014-12-11 JP JP2016538636A patent/JP6200596B2/ja not_active Expired - Fee Related
- 2014-12-11 CA CA2929562A patent/CA2929562A1/en not_active Abandoned
- 2014-12-11 SI SI201431139T patent/SI3083554T1/sl unknown
- 2014-12-11 RS RS20190469A patent/RS58594B1/sr unknown
- 2014-12-11 DK DK14827908.6T patent/DK3083554T3/da active
- 2014-12-11 US US15/030,891 patent/US10005721B2/en not_active Expired - Fee Related
- 2014-12-11 KR KR1020167015772A patent/KR101937186B1/ko active IP Right Grant
- 2014-12-11 EA EA201690911A patent/EA028675B1/ru not_active IP Right Cessation
- 2014-12-11 PL PL14827908T patent/PL3083554T3/pl unknown
-
2016
- 2016-06-14 SA SA516371324A patent/SA516371324B1/ar unknown
-
2019
- 2019-04-29 HR HRP20190793TT patent/HRP20190793T1/hr unknown
- 2019-05-08 CY CY20191100495T patent/CY1121677T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK3083554T3 (da) | 2019-05-13 |
| EA201690911A1 (ru) | 2016-09-30 |
| HUE043614T2 (hu) | 2019-08-28 |
| ME03398B (me) | 2020-01-20 |
| ES2727329T3 (es) | 2019-10-15 |
| SA516371324B1 (ar) | 2018-03-22 |
| JP2017500309A (ja) | 2017-01-05 |
| EA028675B1 (ru) | 2017-12-29 |
| PL3083554T3 (pl) | 2019-08-30 |
| TR201904327T4 (tr) | 2019-04-22 |
| CN105793236A (zh) | 2016-07-20 |
| RS58594B1 (sr) | 2019-05-31 |
| HRP20190793T1 (hr) | 2019-06-28 |
| PT3083554T (pt) | 2019-06-11 |
| AU2014366371B2 (en) | 2017-02-16 |
| JP6200596B2 (ja) | 2017-09-20 |
| KR20160086905A (ko) | 2016-07-20 |
| SI3083554T1 (sl) | 2019-04-30 |
| AU2014366371A1 (en) | 2016-05-19 |
| US20160251306A1 (en) | 2016-09-01 |
| CY1121677T1 (el) | 2020-07-31 |
| KR101937186B1 (ko) | 2019-01-10 |
| MX368178B (es) | 2019-09-23 |
| EP3083554B1 (en) | 2019-03-13 |
| CN105793236B (zh) | 2017-10-10 |
| WO2015094912A1 (en) | 2015-06-25 |
| CA2929562A1 (en) | 2015-06-25 |
| US10005721B2 (en) | 2018-06-26 |
| EP3083554A1 (en) | 2016-10-26 |
| MX2016007861A (es) | 2017-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249518B (en) | A compound that inhibits trk | |
| AP2015008713A0 (en) | Tetrahydropyrrolothiazine compounds | |
| GB201309085D0 (en) | Compounds | |
| GB201302927D0 (en) | Compounds | |
| ME03398B (me) | Spojevi dimetilbenzojeve kiseline | |
| GB201302368D0 (en) | Compound | |
| HK1219100A1 (zh) | 吡啶基吡唑並喹啉化合物 | |
| AP3850A (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| EP2947066A4 (en) | PHENOXYALKYLAMINVERBINDUNG | |
| EP3010923A4 (en) | PYRROLOCHINAZOLINVERBINDUNGEN | |
| EP2948457A4 (en) | COMPOUNDS | |
| GB201307331D0 (en) | Compound | |
| GB201408643D0 (en) | Compound | |
| GB201306794D0 (en) | Compounds | |
| GB201322438D0 (en) | Compound | |
| GB201315772D0 (en) | Compound | |
| GB201305634D0 (en) | Compound | |
| GB201304250D0 (en) | Compound | |
| GB201301585D0 (en) | Compound | |
| GB201309015D0 (en) | Compounds | |
| GB201308975D0 (en) | Compounds | |
| GB201308409D0 (en) | Compounds | |
| GB201307938D0 (en) | Compounds | |
| GB201307093D0 (en) | Compounds | |
| GB201304694D0 (en) | Compounds |